<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37369873</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Characterization of virus-mediated autoimmunity and the consequences for pathological process in patients with systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>2799</StartPage><EndPage>2809</EndPage><MedlinePgn>2799-2809</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-023-06597-6</ELocationID><Abstract><AbstractText Label="INTRODUCTION/OBJECTIVES" NlmCategory="OBJECTIVE">This study aimed to identify differentially expressed genes (DEGs) of systemic lupus erythematosus (SLE) using gene expression-based computational methodologies to analyze disease-immune interactions, which affect the development and progression of SLE.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Twenty-six patients with SLE and 46 healthy controls were selected from the Gene Expression Omnibus (GEO) database. The significantly enriched immune and virus-related gene lists were computed and visualized by using the DEGs from the gene set enrichment analysis (GSEA). Quantification of 38 immune cells was performed in determining the impact of immune cells on the virus mediated immunity in SLE by using ImmQuant algorithm.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-nine upregulated and 57 downregulated were identified in SLE patient compared to the healthy controls. Upregulated genes were significantly implicated in Gene Ontology gene sets as cytokine mediated signaling, secretion, and exocytosis in immune response pathways in 26 female SLE patients. In addition, these genes were enriched in hepatitis C, influenza A, measles, Epstein-Barr virus, and herpes simplex virus 1 infection in Kyoto Encyclopedia of Genes and Genomes pathways. Especially, FCGR1A, IRF7, OAS2, CAMP, MX1, OAS3, OAS1, DEFA3, ISG15, and RSAD2 were involved in virus mediated SLE mechanism, and the expression for OAS1, OAS2, and IRF7 was closely associated with the quantities of colony forming unit-monocyte and colony forming unit-granulocyte.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Identifying virus-mediated SLE genes and quantifies of immune cells were used to understand the pathological process and perform early diagnosis of female SLE, and will lead to clinical tools for treating SLE in patients. Key Points &#x2022; Using gene expression-based computational methodologies,&#xa0;the 57&#xa0;immune and viral genes were significantly upregulated in 26 SLE patients. &#x2022; The identified&#xa0;three key&#xa0; viral genes&#xa0;such as OAS1, OAS2, and IF7 were closely associated with colony-forming unit-monocytes and colony-forming unit-granulocytes, which affect the virus mediated immunity in SLE. &#x2022; The viral genes and quantifies of immune cells are useful in understanding pathogenesis of SLE, and this will provide clinical strategies&#xa0;of potential treatment choices&#xa0;in SLE patients.</AbstractText><CopyrightInformation>&#xa9; 2023. International League of Associations for Rheumatology (ILAR).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ahreum</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4129-9411</Identifier><AffiliationInfo><Affiliation>Department of Education and Training, CHA Bundang Medical Center, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Sung Jae</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0002-0717-1203</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Korea University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Gwan Gyu</ForeName><Initials>GG</Initials><Identifier Source="ORCID">0000-0002-6522-2240</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Korea University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Joo-Hang</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Education and Training, CHA Bundang Medical Center, Seongnam, Republic of Korea. kim123@cha.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea. kim123@cha.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Jae Hyun</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0002-3835-3587</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Korea University College of Medicine, Seoul, Republic of Korea. mcfriend82@naver.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea. mcfriend82@naver.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I2200061</GrantID><Agency>Il-Yang Pharm.</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020031" MajorTopicYN="Y">Epstein-Barr Virus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004854" MajorTopicYN="N">Herpesvirus 4, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Differentially expressed gene</Keyword><Keyword MajorTopicYN="N">Gene set enrichment analysis</Keyword><Keyword MajorTopicYN="N">Immune cell quantification</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">Virus-mediated SLE genes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37369873</ArticleId><ArticleId IdType="doi">10.1007/s10067-023-06597-6</ArticleId><ArticleId IdType="pii">10.1007/s10067-023-06597-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ghodke-Puranik Y, Niewold TB (2015) Immunogenetics of systemic lupus erythematosus: A comprehensive review. J Autoimmunity 64:125&#x2013;136. https://doi.org/10.1016/j.jaut.2015.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2015.08.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi M, Ma K, Li Y, Quan M, Han Z, Ding Z, Liang X, Zhang Q, Song L, Liu C (2021) Immunological involvement of microRNAs in the key events of systemic lupus erythematosus. Front Immunol 12:699684. https://doi.org/10.3389/fimmu.2021.699684</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.699684</ArticleId><ArticleId IdType="pubmed">34408748</ArticleId><ArticleId IdType="pmc">8365877</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok CC, Lau CS (2003) Pathogenesis of systemic lupus erythematosus. J Clin Pathol 56(7):481&#x2013;490. https://doi.org/10.1136/jcp.56.7.481</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.56.7.481</ArticleId><ArticleId IdType="pubmed">12835292</ArticleId><ArticleId IdType="pmc">1769989</ArticleId></ArticleIdList></Reference><Reference><Citation>Gergianaki I, Bortoluzzi A, Bertsias G (2018) Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 32(2):188&#x2013;205. https://doi.org/10.1016/j.berh.2018.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2018.09.004</ArticleId><ArticleId IdType="pubmed">30527426</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceccarelli F, Perricone C, Borgiani P, Ciccacci C, Rufini S, Cipriano E, Alessandri C, Spinelli FR, SiliScavalli A, Novelli G, Valesini G, Conti F (2015) Genetic factors in systemic lupus erythematosus: contribution to disease phenotype. J Immunol Res 2015:745647. https://doi.org/10.1155/2015/745647</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/745647</ArticleId><ArticleId IdType="pubmed">26798662</ArticleId><ArticleId IdType="pmc">4699011</ArticleId></ArticleIdList></Reference><Reference><Citation>Teruel M, Alarc&#xf3;n-Riquelme ME (2016) The genetic basis of systemic lupus erythematosus: what are the risk factors and what have we learned. J Autoimmun 74:161&#x2013;175. https://doi.org/10.1016/j.jaut.2016.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2016.08.001</ArticleId><ArticleId IdType="pubmed">27522116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos PS, Brown EE, Kimberly RP, Langefeld CD (2010) Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis. Semin Nephrol 30(2):164&#x2013;176. https://doi.org/10.1016/j.semnephrol.2010.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semnephrol.2010.01.007</ArticleId><ArticleId IdType="pubmed">20347645</ArticleId><ArticleId IdType="pmc">2847514</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow MK, Kirou KA, Wohlgemuth J (2003) Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 36(8):481&#x2013;490. https://doi.org/10.1080/08916930310001625952</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930310001625952</ArticleId><ArticleId IdType="pubmed">14984025</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalina MD, Bachali P, Geraci NS, Grammer AC, Lipsky PE (2019) Gene expression analysis delineates the potential roles of multiple interferons in systemic lupus erythematosus. Commun Biol 2:140. https://doi.org/10.1038/s42003-019-0382-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-019-0382-x</ArticleId><ArticleId IdType="pubmed">31044165</ArticleId><ArticleId IdType="pmc">6478921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Zhao Y, Lin Y, Yang X, Yan M, Min Y, Pan Z, Xia S, Shao Q (2018) Bioinformatics analysis of differentially expressed gene profiles associated with systemic lupus erythematosus. Mol Med Rep 17(3):3591&#x2013;3598. https://doi.org/10.3892/mmr.2017.8293</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.8293</ArticleId><ArticleId IdType="pubmed">29257335</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauwerys BR, Hachulla E, Spertini F, Lazaro E, Jorgensen C, Mariette X, Haelterman E, Grouard-Vogel G, Fanget B, Dhellin O, Vandepapeli&#xe8;re P, Houssiau FA (2013) Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon &#x3b1;-kinoid. Arthritis Rheum 65(2):447&#x2013;456. https://doi.org/10.1002/art.37785</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.37785</ArticleId><ArticleId IdType="pubmed">23203821</ArticleId></ArticleIdList></Reference><Reference><Citation>Wither JE, Prokopec SD, Noamani B, Chang NH, Bonilla D, Touma Z, Avila-Casado C, Reich HN, Scholey J, Fortin PR, Boutros PC, Landolt-Marticorena c, (2018) Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms. PLoS One 13(5):e0196117. https://doi.org/10.1371/journal.pone.0196117</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0196117</ArticleId><ArticleId IdType="pubmed">29742110</ArticleId><ArticleId IdType="pmc">5942792</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautier L, Cope L, Bolstad BM, Irizarry RA (2004) affy&#x2014;analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20(3):307&#x2013;315. https://doi.org/10.1093/bioinformatics/btg405</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btg405</ArticleId><ArticleId IdType="pubmed">14960456</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim A, Lim SM, Kim JH, Seo JS (2021) Integrative genomic and transcriptomic analyses of tumor suppressor genes and their role on tumor microenvironment and immunity in lung squamous cell carcinoma. Front Immunol 12:598671. https://doi.org/10.3389/fimmu.2021.598671</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.598671</ArticleId><ArticleId IdType="pubmed">33717076</ArticleId><ArticleId IdType="pmc">7948518</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545&#x2013;15550. https://doi.org/10.1073/pnas.0506580102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506580102</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId><ArticleId IdType="pmc">1239896</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo JS, Lee JW, Kim A, Shin JY, Jung YJ, Lee SB, Kim YH, Park S, Lee HJ, Park IK, Kang CH, Yun JY, Kim J, Kim YT (2018) Whole exome and transcriptome analyses integrated with microenvironmental immune signatures of lung squamous cell carcinoma. Cancer Immunol Res 6(7):848&#x2013;859. https://doi.org/10.1158/2326-6066.CIR-17-0453</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2326-6066.CIR-17-0453</ArticleId><ArticleId IdType="pubmed">29720381</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Anders S, Kim V, Huber W (2015) RNA-Seq workflow: gene-level exploratory analysis and differential expression. F1000Res 4:1070. https://doi.org/10.12688/f1000research.7035.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.7035.1</ArticleId><ArticleId IdType="pubmed">26674615</ArticleId><ArticleId IdType="pmc">4670015</ArticleId></ArticleIdList></Reference><Reference><Citation>Frishberg A, Brodt A, Steuerman Y, Gat-Viks I (2016) ImmQuant: a user-friendly tool for inferring immune cell-type composition from gene-expression data. Bioinformatics 32(24):3842&#x2013;3843. https://doi.org/10.1093/bioinformatics/btw535</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw535</ArticleId><ArticleId IdType="pubmed">27531105</ArticleId><ArticleId IdType="pmc">5167062</ArticleId></ArticleIdList></Reference><Reference><Citation>Almaani S, Meara A, Rovin BH (2017) Update on lupus nephritis. Clin J Am Soc Nephrol 12(5):825&#x2013;835. https://doi.org/10.2215/CJN.05780616</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.05780616</ArticleId><ArticleId IdType="pubmed">27821390</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson P, Rylance P, Roden D, Trela M, Tugnet N (2014) Viruses as potential pathogenic agents in systemic lupus erythematosus. Lupus 23(6):596&#x2013;605. https://doi.org/10.1177/0961203314531637</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314531637</ArticleId><ArticleId IdType="pubmed">24763543</ArticleId></ArticleIdList></Reference><Reference><Citation>Jog NR, James JA (2020) Epstein Barr virus and autoimmune responses in systemic lupus erythematosus. Front Immunol 11:623944. https://doi.org/10.3389/fimmu.2020.623944</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.623944</ArticleId><ArticleId IdType="pubmed">33613559</ArticleId></ArticleIdList></Reference><Reference><Citation>Spihlman AP, Gadi N, Wu SC, Moulton VR (2020) COVID-19 and systemic lupus erythematosus: focus on immune response and therapeutics. Front Immunol 11:589474. https://doi.org/10.3389/fimmu.2020.589474</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.589474</ArticleId><ArticleId IdType="pubmed">33193418</ArticleId><ArticleId IdType="pmc">7661632</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok CC, Tse SM, Chan KL, Ho LY (2018) Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort. Lupus 27(5):722&#x2013;727. https://doi.org/10.1177/0961203317739129</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203317739129</ArticleId><ArticleId IdType="pubmed">29087260</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrada AA, Escobedo N, Iruretagoyena M, Valenzuela RA, Burgos PI, Cuitino L (2019) Llanos C (2019) Innate immune cells&#x2019; contribution to systemic lupus erythematosus. Front Immunol 10:772. https://doi.org/10.3389/fimmu.2019.00772</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00772</ArticleId><ArticleId IdType="pubmed">31037070</ArticleId><ArticleId IdType="pmc">6476281</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarra SV, Guzm&#xe1;n RM, Gallacher AE, Hall S, Levy RA, Jimenez RE, Li EK, Thomas M, Kim HY, Le&#xf3;n MG, Tanasescu C, Nasonov E, Lan JL, Pineda L, Zhong ZJ, Freimuth W, Petri MA (2011) Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 377(9767):721&#x2013;731. https://doi.org/10.1016/S0140-6736(10)61354-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61354-2</ArticleId><ArticleId IdType="pubmed">21296403</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamashta M, Merrill JT, Werth VP, Furie R, Kalunian K, Illei GG, Drappa J, Wang L, Greth W (2016) Sifalimumab, an anti-interferon-&#x3b1; monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study. Ann Rheum Dis 75(11):1909&#x2013;1916. https://doi.org/10.1136/annrheumdis-2015-208562</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2015-208562</ArticleId><ArticleId IdType="pubmed">27009916</ArticleId></ArticleIdList></Reference><Reference><Citation>Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, Bae SC, Brohawn PZ, Pineda L, Berglind A, Tummala R (2020) Trial of anifrolumab in active systemic lupus erythematosus. N Engl J Med 382(3):211&#x2013;221. https://doi.org/10.1056/NEJMoa1912196</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1912196</ArticleId><ArticleId IdType="pubmed">31851795</ArticleId></ArticleIdList></Reference><Reference><Citation>Weckerle CE, Niewold TB (2011) The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin Rev Allergy Immunol 40(1):42&#x2013;49. https://doi.org/10.1007/s12016-009-8192-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-009-8192-4</ArticleId><ArticleId IdType="pubmed">20063186</ArticleId><ArticleId IdType="pmc">2891868</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Q, Liu Z, Liao S, Ye L, Lu X, Chen X, Li Z, Li X, Xu YZ, Liu H (2019) Current mechanistic insights into the role of infection in systemic lupus erythematosus. Biomed Pharmacother 117:109122. https://doi.org/10.1016/j.biopha.2019.109122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.109122</ArticleId><ArticleId IdType="pubmed">31226637</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaglia M, Merlotti G, De Andrea M, Borgogna C, Cantaluppi V (2021) Viral infections and systemic lupus erythematosus: new players in an old story. Viruses 13(2):277. https://doi.org/10.3390/v13020277</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020277</ArticleId><ArticleId IdType="pubmed">33670195</ArticleId><ArticleId IdType="pmc">7916951</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreyfus DH (2011) Autoimmune disease: a role for new anti-viral therapies? Autoimmun Rev 11(2):88&#x2013;97. https://doi.org/10.1016/j.autrev.2011.08.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2011.08.005</ArticleId><ArticleId IdType="pubmed">21871974</ArticleId></ArticleIdList></Reference><Reference><Citation>Gies V, Bekaddour N, Dieudonn&#xe9; Y, Guffroy A, Frenger Q, Gros F, Rodero MP, Herbeuval JP, Korganow AS (2020) Beyond anti-viral effects of chloroquine/hydroxychloroquine. Front Immunol 11:1409. https://doi.org/10.3389/fimmu.2020.01409</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01409</ArticleId><ArticleId IdType="pubmed">32714335</ArticleId><ArticleId IdType="pmc">7343769</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed M (2018) Era of direct acting anti-viral agents for the treatment of hepatitis C. World J Hepatol 10(10):670&#x2013;684. https://doi.org/10.4254/wjh.v10.i10.670</Citation><ArticleIdList><ArticleId IdType="doi">10.4254/wjh.v10.i10.670</ArticleId><ArticleId IdType="pubmed">30386460</ArticleId><ArticleId IdType="pmc">6206157</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis L, Perl A (2010) Infection in systemic lupus erythematosus: friend or foe? Int J Clin Rheumtol 5(1):59&#x2013;74. https://doi.org/10.2217/ijr.09.72</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/ijr.09.72</ArticleId><ArticleId IdType="pubmed">20209114</ArticleId><ArticleId IdType="pmc">2830655</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliorini A, Anders HJ (2012) A novel pathogenetic concept-antiviral immunity in lupus nephritis. Nat Rev Nephrol 8(3):183&#x2013;189. https://doi.org/10.1038/nrneph.2011.197</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2011.197</ArticleId><ArticleId IdType="pubmed">22249778</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisching G, Wiid I, Baker B (2018) OAS1, 2, and 3: Significance during active tuberculosis? J Infect Dis 217(10):1517&#x2013;1521. https://doi.org/10.1093/infdis/jiy084</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiy084</ArticleId><ArticleId IdType="pubmed">29452387</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng X, Huang J, Liu Y, Xiao L, Wang D, Hua B, Tsao BP, Sun L (2015) Identification of interferon-inducible genes as diagnostic biomarker for systemic lupus erythematosus. Clin Rheumatol 34(1):71&#x2013;79. https://doi.org/10.1007/s10067-014-2799-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-014-2799-4</ArticleId><ArticleId IdType="pubmed">25344775</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu WD, Zhang YJ, Xu K, Zhai Y, Li BZ, Pan HF, Ye DQ (2012) IRF7, a functional factor associates with systemic lupus erythematosus. Cytokine 58(3):317&#x2013;320. https://doi.org/10.1016/j.cyto.2012.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2012.03.003</ArticleId><ArticleId IdType="pubmed">22455868</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>